Such reports shall provide all information requested by WADA  accurately and completely, explain the reasons for any Non -Conformities  identified, and describe the efforts the Signatory has made and/or proposes to make to correct such Non-Conformities ; 7.4.1.2  conducting Compliance Audits  of Signatories ’ ongoing Anti-Doping Programs , in accordance with Article 7 .7, in order to assess their Code  Compliance , to identify and categorize Non -Conformities , and to identify corrective actions required to correct the Non-Conformities  and so achieve full Code Compliance ; 7.4.1.3  conducting Independent Observer Programs (a) at the Olympic Games and the Paralympic Games, and (b) at other selected Events ; 7.4.1.4  reviewing the adequacy of Signatories’ responses to requests made or endorsed by WADA to implement Target Testing and/or other measures in the lead- up to the Olympic Games or Paralympic Games or other Event ;  7.4.1.5  reviewing the following key documents:        ISCCS – January 2021   Page 27 of 61 (a) Signatories ’ rules and regulations (and/or relevant legislation, if that is how the Code has been implemented in a particular country);  (b) Signatories ’ Risk Assessments  and Test Distribution Plans  provided in accordance with Code Article 5.4  and Article 4.1.3 of the  International Standard for Testing and Investigations ;  (c) Signatories ’ annual statistical reports of their respective Doping Control activities provided in accordance with Code  Article 14.4;  (d) Doping Control forms, TUE decisions, and other data filed in ADAMS (including assessing compliance with requirements to file such information in ADAMS within specified timeframes, and reviewing TUE decisions for compliance with the International Standard  for Therapeutic Use Exemptions );  (e) reports compiled by other relevant bodies (e.g., reports from country visits conducted by the Monitoring Group of the Anti -Doping Convention of the Council of Europe); and  (f) any other documents or data requested by WADA Management from the Signatory in order to assess the Signatory ’s Code Compliance ; 7.4.1.6  conducting other continuous compliance monitoring activities in accordance with Article 7 .8; 7.4.1.7  reviewing Results Management  decisions made by Signatories  and communicated to WADA in accordance with Code Articles 7.6 and 14.1.4 , and the International Standard for Results Management , including (without limitation) decisions by Signatories :  (a) not to bring an Atypical Fin ding forward as an Adverse Analytical Finding;  (b) not to bring an Adverse Analytical Finding or an Adverse Passport Finding forward as an anti -doping rule violation;  (c) not to bring Whereabouts Failures or other apparent violations forward as anti -doping rule violations;  (d) to withdraw the allegation of an anti -doping rule violation; and  (e) to agree on the outcome of proceedings alleging an anti -doping rule violation without first holding a hearing;  provided that, save in exceptional cases, WADA  will not allege that a Signatory  is non- compliant based solely on a single non- compliant Results Management  decision.